PPA
GBT

Parametric Portfolio Associates’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Parametric Portfolio Associates’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$3.26M Sell
94,062
-20,247
-18% -$605K ﹤0.01% 2131
2021
Q4 		$3.35M Buy
114,309
+17,391
+18% +$539K ﹤0.01% 2127
2021
Q3 		$2.47M Buy
96,918
+24,017
+33% +$706K ﹤0.01% 2319
2021
Q2 		$2.55M Buy
72,901
+29,402
+68% +$1.15M ﹤0.01% 2298
2021
Q1 		$1.77M Sell
43,499
-324
-0.7% -$14.9K ﹤0.01% 2865
2020
Q4 		$1.9M Sell
43,823
-2,465
-5% -$122K ﹤0.01% 2686
2020
Q3 		$2.55M Sell
46,288
-20,320
-31% -$1.29M ﹤0.01% 2355
2020
Q2 		$4.21M Buy
66,608
+19,133
+40% +$1.31M ﹤0.01% 1992
2020
Q1 		$2.42M Sell
47,475
-9,764
-17% -$654K ﹤0.01% 2253
2019
Q4 		$4.55M Buy
57,239
+16,294
+40% +$966K ﹤0.01% 2131
2019
Q3 		$1.99M Sell
40,945
-3,921
-9% -$204K ﹤0.01% 2638
2019
Q2 		$2.36M Buy
44,866
+34,541
+335% +$1.98M ﹤0.01% 2555
2019
Q1 		$547K Buy
10,325
+3,951
+62% +$194K ﹤0.01% 3289
2018
Q4 		$262K Buy
6,374
+1,077
+20% +$40.4K ﹤0.01% 3567
2018
Q3 		$201K Sell
5,297
-1,295
-20% -$57.4K ﹤0.01% 3762
2018
Q2 		$298K Sell
6,592
-21,521
-77% -$980K ﹤0.01% 3559
2018
Q1 		$1.36M Sell
28,113
-1,755
-6% -$97.9K ﹤0.01% 2845
2017
Q4 		$1.18M Sell
29,868
-6,059
-17% -$226K ﹤0.01% 2929
2017
Q3 		$1.12M Buy
35,927
+4,984
+16% +$140K ﹤0.01% 2970
2017
Q2 		$846K Buy
30,943
+284
+0.9% +$8.45K ﹤0.01% 3076
2017
Q1 		$1.13M Buy
+30,659
New +$772K ﹤0.01% 2805

Other funds holding GBT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Parametric Portfolio Associates's GBT Position: Q1 2022 in Review

Parametric Portfolio Associates reduced its Global Blood Therapeutics, Inc. (GBT) stake by 18% in Q1 2022, selling an estimated $605K and leaving 94,062 shares worth $3.26M. The position accounts for ﹤0.01% of the portfolio, ranked #2131.

Parametric Portfolio Associates first reported a position in GBT in Q1 2017 and has held it in 21 quarters since. The position peaked at $4.55M in Q4 2019. 204 funds tracked by Wall St. Rank hold GBT as of Q1 2022.

  • Parametric Portfolio Associates held 94,062 shares of Global Blood Therapeutics, Inc. worth $3.26M as of Q1 2022.
  • Parametric Portfolio Associates sold 20,247 Global Blood Therapeutics, Inc. shares in Q1 2022, an estimated $605K.
  • Global Blood Therapeutics, Inc. made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #2131 holding.
  • Parametric Portfolio Associates first reported a position in Global Blood Therapeutics, Inc. in Q1 2017 and has held it in 21 quarters since.
  • Parametric Portfolio Associates's Global Blood Therapeutics, Inc. position peaked at $4.55M in Q4 2019.
  • 204 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.